XML 30 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
C. STOCKHOLDERS EQUITY (Tables)
3 Months Ended
Dec. 31, 2012
C. Stockholders Equity Tables  
Stock options, stock bonuses and compensation granted by the Company
Name of Plan   

Total 

Shares

Reserved 

Under Plans

   

Shares

Reserved for 

Outstanding 

Options

   

Shares

Issued as

Stock Bonus

   

Remaining

Options/Shares

Under Plans

 
                         
Incentive Stock Option Plans     21,100,000       13,898,275       N/A       5,135,225  
Non-Qualified Stock Option Plans(1)       57,760,000       34,573,813       N/A       16,871,573  
Stock Bonus Plans       15,940,000       N/A       8,345,844       7,589,642  
Stock Compensation Plan       13,500,000       N/A       6,886,531       6,613,469  
Schedule of employees and non-employees stock compensation
    Three Months Ended December 31,  
    2012     2011  
 Employees   $ 966,585     $ 837,458  
 Non-employees   $ 107,818     $ 38,670  
Derivative Liabilities, Warrants and Other Options
Warrant   Issue Date   Shares Issuable upon Exercise of Warrant     Exercise Price   Expiration Date   Refer-ence  
                         
Series N   8/18/08     5,187,709       0.30   8/18/14     1  
Series A   6/24/09     1,303,472       0.50   12/24/14     1  
C. Schleuning (Series A)   7/8/09     167,500       0.50   01/08/15     1  
Series B   9/4/09     500,000       0.68   9/4/14     1  
Series C   8/20/09 – 8/26/09     4,634,886       0.55   2/20/15     1  
Series E   9/21/09     714,286       1.75   8/12/14     1  
Series F   10/6/11     12,000,000       0.40   10/6/14     1  
Series G   10/6/11     666,667       0.40   8/12/14     1  
Series H   1/26/12     12,000,000       0.50   8/1/15     1  
Series Q   6/21/12     12,000,000       0.50   12/22/15     1  
Series R   12/6/12     26,250,000       0.40   12/6/16     1  
                               
Series L   4/18/07     250,000       0.75   4/17/14     2  
Series L (repriced)   4/18/07     1,000,000       0.34   4/17/13     2  
Series M (modified)   4/18/07     6,000,000       0.34   7/31/14     2  
                               
Series P   2/10/12     5,900,000       0.45   3/6/17     3  
                               
Private Investors   5/30/03- 6/30/09     8,609,375       0.47 – 1.25   5/30/13 - 7/18/14     4  
                               
Warrants held by Officer and Director   6/24/09- 7/6/09     3,497,539       0.40 – 0.50   12/24/14 – 1/6/15     5  
Consultants   5/22/03 – 12/28/12     1,437,500       0.28 – 2.00   5/22/13 - 12/28/17     6  
Tabular disclosure of derivative liabilities at fair value
    December 31, 2012     September 30, 2012  
Series A through E warrants   $ 454,553     $ 786,989  
Series N warrants     518,772       830,034  
Series F and G warrants     1,006,667       1,646,667  
Series H warrants     1,200,000       1,800,000  
Series Q warrants     1,320,000       1,920,000  
Series R warrants     3,937,500       -  
                 
Total derivative liabilities   $ 8,437,492     $ 6,983,690